Anavex Life Sciences Reports Promising Results in Parkinson’s Disease Study
OnAnavex Life Sciences, a biopharmaceutical firm specializing in innovative treatments for neurodegenerative and neurodevelopmental disorders, has announced the successful completion of a 48-week Phase.
Read More